Research Article

miR-432-5p Inhibits the Ferroptosis in Cardiomyocytes Induced by Hypoxia/Reoxygenation via Activating Nrf2/SLC7A11 Axis by Degrading Keap1

Figure 2

The activation of the Nrf2/SLC7A11/GPX4/HO-1 pathway protects cardiomyocytes from ferroptosis: (a) the ferroptosis inducer RSL3 (1.5 μM) reduced the viability of cardiomyocytes significantly; (b–d) RSL3-induced ferroptosis caused increased MDA and PTGS2 levels and the downregulated ratio of GSH/GSSG; (e) representative western blot image of protein expressions. Pretreatment of Nrf2 activator, mangiferin, suppressed apoptosis of cardiomyocytes induced by RSL3; increased Nrf2, GPX4, SLC7A11, HO-1, and UCP3 expression, while the Nrf2 inhibitor, brusatol (10 nM), aggravates the ferroptosis by decreasing Nrf2, SLC7A11, HO-1, and UCP3 expressions. , ; N = 3.
(a)
(b)
(c)
(d)
(e)